Answers are grounded in this paper and cite their sources.
Feasibility study demonstrates sufficient red blood cell production from umbilical cord blood for extremely low gestational age neonates, indicating a potential alternative to adult donor blood.
Considering the data obtained about RBC transfusion needs and morbidities, the ELGAN group has been identified as the target group that would benefit most from UCB-RBC transfusions. We have demonstrated that our blood bank is able to produce enough RBC from UCB. Randomised control trials are warranted to study the potential benefits of UCB compared to adult blood for RBC transfusions.
No takes yet. Share an insight, caveat, or question.
González et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: